Activity from announced rounds
Khosla Ventures funds technology companies at seed, early and growth stages, including businesses tackling difficult scientific and engineering problems in energy, industry, healthcare and software.
Its investments in fusion and lower-emission cement illustrate an appetite for technical risk in markets where commercialisation requires more than a software launch. The firm also invests in AI and developer businesses, applying the same interest in technology that can change how an industry works.
Its Venture Assistance programme includes candidate shortlists, compensation and hiring-close materials, recruiting events and operator office hours in growth, product marketing, data and sales. Those are practical resources for founders assembling the team and commercial capability around a technical product.
Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.
Builds formal verification tools ensuring AI reliability in law, drug discovery, and tax prep
Platform that unifies patient health records for individuals and supplies anonymized data to pharma researchers
Develops biotech-powered hair supplements using proprietary microencapsulation
Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases
Loyal develops medicines intended to extend dogs’ lifespans.